HARVEST FUND MGMTHARVEST FUND MGMTHARVEST FUND MGMT

HARVEST FUND MGMT

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪1.30 B‬CNY
Fund flows (1Y)
‪405.54 M‬CNY
Dividend yield (indicated)
Discount/Premium to NAV
0.7%
Shares outstanding
‪1.39 B‬
Expense ratio
0.60%

About HARVEST FUND MGMT


Issuer
Harvest Fund Management Co., Ltd.
Brand
Harvest ETFs
Home page
Inception date
Dec 26, 2023
Structure
Open-Ended Fund
Index tracked
S&P Biotechnology Select Industry
Replication method
Physical
Management style
Passive
Primary advisor
Harvest Fund Management Co., Ltd.
ISIN
CNE100006CZ5
The Fund closely tracks the underlying index and pursues the minimization of tracking deviation and tracking err.

Classification


Asset Class
Equity
Category
Size and style
Focus
Total market
Niche
Broad-based
Strategy
Vanilla
Geography
China
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of December 31, 2024
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.41%
Health Technology97.14%
Health Services2.26%
Bonds, Cash & Other0.59%
Cash0.59%
Stock breakdown by region
96%3%
North America96.05%
Europe3.95%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


159502 invests in stocks. The fund's major sectors are Health Technology, with 97.14% stocks, and Health Services, with 2.26% of the basket. The assets are mostly located in the North America region.
159502 top holdings are Neurocrine Biosciences, Inc. and AbbVie, Inc., occupying 2.54% and 2.43% of the portfolio correspondingly.
159502 assets under management is ‪1.30 B‬ CNY. It's risen 4.39% over the last month.
159502 fund flows account for ‪405.54 M‬ CNY (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 159502 doesn't pay dividends to its holders.
159502 shares are issued by Harvest Fund Management Co., Ltd. under the brand Harvest ETFs. The ETF was launched on Dec 26, 2023, and its management style is Passive.
159502 expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
159502 follows the S&P Biotechnology Select Industry. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
159502 invests in stocks.
159502 price has risen by 5.51% over the last month, and its yearly performance shows a −16.40% decrease. See more dynamics on 159502 price chart.
NAV returns, another gauge of an ETF dynamics, showed a 10.96% increase in three-month performance and has decreased by −13.59% in a year.
159502 trades at a premium (0.67%) meaning the ETF is trading at a higher price than the calculated NAV.